|
MFSD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.310800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.069600E-01 |
| Normal-vs-Stage2 |
7.060800E-01 |
| Normal-vs-Stage3 |
9.885700E-02 |
| Normal-vs-Stage4 |
4.815200E-01 |
| Stage1-vs-Stage2 |
8.824000E-01 |
| Stage1-vs-Stage3 |
1.012130E-02 |
| Stage1-vs-Stage4 |
1.949200E-01 |
| Stage2-vs-Stage3 |
1.487570E-01 |
| Stage2-vs-Stage4 |
4.193600E-01 |
| Stage3-vs-Stage4 |
6.373400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.799400E-01 |
| Normal-vs-AfricanAmerican |
7.978000E-01 |
| Normal-vs-Asian |
3.294000E-01 |
| Caucasian-vs-AfricanAmerican |
8.530200E-01 |
| Caucasian-vs-Asian |
2.563200E-01 |
| AfricanAmerican-vs-Asian |
2.611400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.879600E-01 |
| Normal-vs-Female |
4.985200E-01 |
| Male-vs-Female |
3.388400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.424200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.534000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.920800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.917800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.165000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.628200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.240020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.130200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.779500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.308800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.941000E-01 |
| Normal-vs-Grade 2 |
5.653800E-01 |
| Normal-vs-Grade 3 |
6.201000E-01 |
| Normal-vs-Grade 4 |
5.867600E-01 |
| Grade 1-vs-Grade 2 |
8.285800E-01 |
| Grade 1-vs-Grade 3 |
5.616800E-01 |
| Grade 1-vs-Grade 4 |
4.026800E-01 |
| Grade 2-vs-Grade 3 |
3.038000E-01 |
| Grade 2-vs-Grade 4 |
3.890800E-01 |
| Grade 3-vs-Grade 4 |
8.024600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.646400E-01 |
| Normal-vs-ccB subtype |
2.877200E-01 |
| ccA subtype-vs-ccB subtype |
1.852970E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.470800E-01 |
| Normal-vs-N1 |
4.607000E-01 |
| N0-vs-N1 |
5.177000E-01 |
|
|
